
|Articles|December 1, 2003
FDA trial for toric ICL addresses myopic astigmatism
Cincinnati, OH-Early results from an FDA clinical trial suggest that the toric implantable contact lens (ICL, STAAR Surgical) is extremely promising as a safe and effective alternative to LASIK for the correction of myopia with astigmatism, reported David Schneider, MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Self-Screening for Ocular Surface Malignancies Using a Smartphone
2
Everest Medicines acquires Greater China rights to Aceclidine Presbyopia Eye Drop (VIZZ)
3
Rising Star: Introducing Viha Vig, MBChB
4
Phase 3 NORTHSTAR Trial Launches for Gildeuretinol in Stargardt Disease
5





















